In search of the Infinity Gauntlet. Could KRAS be the problem and, at the same time, hold the answer to the deadliest cancers?

Review of KRAS research from recent years. Advances in the discovery of therapeutic targets, drugs, and expectations for the research of the undruggable oncogene: the protein most frequently mutated in all lethal cancers and the hardest to target with drugs... or so we thought until now.

Led by Jesús Daniel Gómez Zepeda. Predoctoral researcher of the group Signal transduction, intracellular compartments, and cancer.

Talk in Catalan. Free entrance. Limited capacity, with prior reservation.